Improving the utilization of clinical laboratory tests

Journal of Evaluation in Clinical Practice

Volumn 4, Issue 3, 1998, Pages 171-181

  Wu, Alan H B ^a,b  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Point of care; Profiles; Repeat tests; Screening tests; Utilization

Indexed keywords

ALGORITHM; BIOMEDICAL TECHNOLOGY ASSESSMENT; COST CONTROL; DECISION TREE; DIAGNOSIS, MEASUREMENT AND ANALYSIS; DIAGNOSTIC TEST; ECONOMICS; EXPERT SYSTEM; HOSPITAL INFORMATION SYSTEM; HOSPITAL LABORATORY; HUMAN; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; REIMBURSEMENT; REVIEW; SENSITIVITY AND SPECIFICITY; STANDARD; TOTAL QUALITY MANAGEMENT; UNITED STATES; UTILIZATION REVIEW;

ALGORITHMS; COST CONTROL; DECISION TREES; DIAGNOSTIC TESTS, ROUTINE; EFFICIENCY, ORGANIZATIONAL; EXPERT SYSTEMS; HUMANS; LABORATORIES, HOSPITAL; LABORATORY TECHNIQUES AND PROCEDURES; POINT-OF-CARE SYSTEMS; PRACTICE GUIDELINES; REIMBURSEMENT MECHANISMS; SENSITIVITY AND SPECIFICITY; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TOTAL QUALITY MANAGEMENT; UNITED STATES;

EID: 0032135571     PISSN: 13561294     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2753.1998.00001.x     Document Type: Article

References (43)

1. Allen L.V. & Stiles M.L. (1981) Specificity of the EMIT drug abuse urine assay methods. Clinical Toxicology 18, 1043-1065.
2. Bailey A. (1974) Biochemistry of well populations. Lancet 2, 1436-9.
3. Blomberg D.J., Ladley J.L., Fattu J.M. & Patrick E.A. (1987) The use of an expert system in the clinical laboratory as an aid in the diagnosis of anemia. American Journal of Clinical Pathology, 87, 608-613.
4. Branger P.J., Van Oers R.J.M., Van Der Wouden J.C. & van der Lei J. (1995). Laboratory services utilization: a survey of repeat investigations in ambulatory care. Netherlands Journal of Medicine 47, 208-213.
5. Braunwald E. et al. (1994) Unstable Angina: Diagnosis and Management. Agency for Health Care Policy and Research, Rockville, MD.
6. Cebul R.D. & Beck J.R. (1987) Biochemistry profiles: applications in ambulatory screening and preadmission testing of adults. Annals of Internal Medicine 106, 403-413.
7. Chernesky M.A., Jang D., Lee H., Burczak J.D., Hu H., Sellers J., Tomazic-Allen S.J. & Mahony J.B. (1994) Diagnosis of Chlamydia trachomatis infections in men and women by testing first-void urine by ligase chain reaction. Journal of Clinical Microbiology 32, 2682-2685.
8. Chu U.B., Clevenger F.W., Imami E.R., Lampard S.D., Frykberg E.R. & Tepas J.J. (1996) The impact of selective laboratory evaluation of utilization of laboratory resources and patient care in a Level-I trauma center. American Journal of Surgery 172, 558-563.
9. Davey R.X., Clarke M.I. & Webster A.R. (1996) Thyroid function testing based on assay of thyroid-stimulating hormone: assessing an algorithm's reliability. Medical Journal of Australia 164, 329-332.
10. Epstein A.M., Handley R.M., Charlton J.R., Harris C.M., Jarman B. & McNeil B.J. (1984) A comparison of ambulatory test ordering for hypotensive patients in the United States and England. Journal of the American Medical Association 252, 1723-1726.
11. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (1993) Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). Journal of the American Medical Association 269, 3015-3023.
12. Garnero P. & Delmas P.D. (1996) New developments in biochemical markers for osteoporosis. Calcium and Tissue International 59 (Suppl.), S2-9.
13. Gumaste W. (1994) Diagnostic tests for acute pancreatitis. Gastroenterology 2, 119-130.
14. Harris C.M., Lloyd D.C., & Lewis J. (1995) The prevalence and prophylaxis of gout in England. Journal of Clinical Epidemiology 48, 1153-1158.
15. Hindmarsh J.T. & Lyon A.W. (1996) Strategies to promote rational clinical chemistry test utilization. Clinical Biochemistry 29, 291-299.
16. Holyoke E.D., Chu T.M. & Murphy G.P. (1975) CEA as a monitor of gastroeintestinal malignancy. Cancer 35, 830-836.
17. Hyams A.L., Brandenburg J.A., Lipsitz S.R., Shapiro D.W. & Brennan T.A. (1995) Practice guidelines and malpractice litigation: a two-way street. Annals of Internal Medicine 122, 450-455.
18. Jaffe A.S., Landt Y., Parvin C.A., Abendschein D.R., Geltman E.M., & Ladenson J.H. (1996) Comparative sensitivity of cardiac troponin I and lactate dehydrogenase isoenzymes for diagnosis of acute myocardial infarction. Clinical Chemistry 42, 1770-1776.
19. Kelly J.T. (1995) Role of clinical practice guidelines and clinical profiling in facilitating optimal laboratory use. Clinical Chemistry 41, 1234-1236.
20. Klee G. & Hay I.D. (1987) Assessment of sensitive thyrotropin assays for an expanded role in thyroid function testing: proposed criteria for analytic performance and clinical utility. Journal of Clinical Encocrinology and Metabolism 64, 461-471.
21. Marcello P.W. & Roberts P.L. (1996) 'Routine' preoperative studies: which studies in which patients? Surgical Clinics of North America 76, 11-23.
22. McDonald C.J. (1976) Use of a computer to detect and respond to clinical events: its effect on clinical behaviour. Annals of Internal Medicine 84, 162-167.
23. Nosanchuk J.S. & Keefner R. (1995) Cost analysis of point-of-care laboratory testing in a community hospital. American Journal of Clinical Pathology 103, 240-243.
24. Oesterling J.E. (1991) Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. Journal of Urology 145, 907-923.
25. Parvin C.A., Lo S.F., Deuser S.M. Weaver L.G., Lewis L.M. & Scott M.G. (1996) Impact of point-of-care testing on patients' length of stay in a large emergency department. Clinical Chemistry 42, 711-717.
26. Rabitzsch G., Mair J., Lechleitner P., Noll F., Hofmann U., Kraus E.G., Dienstl, F. & Puschendorf B. (1995) Immunoenzymometric assay of human glycogen phosophorylase isoenzyme BB in diagnosis of ischemic myocardial injury. Clinical Chemistry 41, 966-978.
27. Rader D.J., Hoeg J.M. & Brewer H.B. (1994) Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Annals of Internal Medicine 120, 1012-1025.
28. Ried D.L., Horn J.R. & McKenna D.A. (1990) Therapeutic drug monitoring reduces toxic drug reactions: a meta-analysis. Therapeutic Drug Monitoring 12, 72-78.
29. Sackett D.L. (1983) The usefulness of laboratory tests in health-screening programs. Clinical Chemistry 19, 366-372.
30. Saxena S., Anderson, D.W., Kaufman, R.L., Hannah, J.A. & Wong, E.T. (1993) Quality assurance study of cardiac isoenzyme utilization in a large teaching hospital. Archives of Pathology Laboratory Medicine 117, 180-183.
31. Scheonenberger R.A., Tansijevic M.J., Jha A. & Bates D.W. (1995) Appropriateness of antiepileptic drug level monitoring. Journal of the American Medical Association 274, 1622-1626.
32. Schwartz M.K., Bethune V.G., Fleisher M., Pennacchia G, Menendez-Botet C.J., & Lehman D. (1974) Chemical and clinical evaluation of the continuous-flow analyzer 'SMAC.' Clinical Chemistry 20, 1062-1070.
33. Sialaff B.H., Scott E.P. & Connelly D.P. (1991). Design and preliminary evaluation of an expert system for platelet request evaluation. Transfusion 31, 600-606.
34. Sporer K.A. & Khayam-Bashi H. (1996) Acetaminophen and salicylate serum levels in patients with suicidal ingestion or altered mental status. American Journal of Emergency Medicine 14, 443-446.
35. Studnicki J., Bradham D.D., Marshburn G., Foulis P.R. & Straumfjord J.V. (1992) Measuring the impact of standing order on laboratory utilization. Laboratory Medicine 23, 24-28.
36. Sunshine J.H. & Evens R.G. (1994) The challenge of managed care and managed competition. American Journal of Radiology 162, 767-771.
37. Turnball J.M. & Buck C. (1987) The value of preoperative screening investigations in otherwise healthy individuals. Archives of Internal Medicine 147, 1101-1105.
38. van Nieuwenhoben F.A., Kleine A.H., Wodzig K.W.H., Hermens W.T., Kragten H.A., Maessen J.G., Punt C.D., van Dieijen M.P., van der Vusse G.J. & Glatz J.F.C. (1995) Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 92, 2848-2854.
39. Weingarten S.R., Riedinger M.S., Conner L., Lee T.H., Hoffman I., Johnson B. & Ellrodt A.G. (1994) Practice guidelines and reminders to reduce duration of hospital stay for patients with chest pain. An interventional trial. Annals of Internal Medicine 120, 257-263.
40. Weiss S.M., Kulikowski C.A., & Galen R.S. (1983) Representing expertise in a computer program: the serum protein diagnostic program. Journal of Clinical Laboratory Automation 3, 383-387.
41. Werner M. (1995) Appropriate utilization and cost control of the hospital laboratory: panel testing and repeat orders. Clinica Chimica Acta 233, 1-17.
42. Whitehead T.P. & Wooton, I.D.P. (1974) Biochemical profiles for hospital patients. Lancet 2, 1439-1943.
43. Wu A.H.B. (1997) Reducing the inappropriate utilization of clinical laboratory tests. Connecticut Medicine 61, 15-21.